Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression

Phytomedicine

Volumn 17, Issue 3-4, 2010, Pages 212-218

  Ren, Z H ^a   Tong, Y H ^a   Xu, W ^a   Ma, J ^a   Chen, Y ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Cardiac fibroblast; Inflammatory responses; MCP 1; Myocardial infarction; Salvia miltiorrhiza; Tanshinone IIA; TGF 1

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TANSHINONE IIA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTERY LIGATION; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; FIBROBLAST; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMODYNAMICS; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CHEMOKINE CCL2; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; FIBROBLASTS; HEART; INFLAMMATION; MACROPHAGES; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; NF-KAPPA B; PHENANTHRENES; PHYTOTHERAPY; PLANT ROOTS; RATS; RATS, SPRAGUE-DAWLEY; SALVIA MILTIORRHIZA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS; SALVIA MILTIORRHIZA;

EID: 75249095628     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.08.010     Document Type: Article

References (29)

1. Arakelyan A., Petrkova J., Hermanova Z., Boyajyan A., Lukl J., and Petrek M. Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction. Mediators Inflammat. 3 (2005) 175-179
2. Bierhaus A., and Nawroth P.P. Modulation of the vascular endothelium during infection-the role of NF-kappa B activation. Contrib. Microbiol. 10 (2003) 86-105
3. Bujak M., and Frangogiannis N.G. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc. Res. 74 (2007) 184-195
4. Dewald O., Zymek P., Winkelmann K., Koerting A., Ren G., Abou-Khamis T., Michael L.H., Rollins B.J., Entman M.L., and Frangogiannis N.G. CCL2/Monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ. Res. 96 (2005) 881-889
5. Fishbein M.C., Maclean D., and Maroko P.R. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am. J. Pathol. 90 (1978) 57-70
6. Fu J., Huang H., Liu J., Pi R., Chen J., and Liu P. Tanshinone IIA protects cardiacmyocytes against oxidative stress-triggered damage and apoptosis. Eur J. Pharmacol. 568 (2007) 213-221
7. Gao J., Yang G., Pi R., Li R., Wang P., Zhang H., Le K., Chen S., and Liu P. Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis. Transl. Res. 151 (2008) 79-87
8. Gharaee-Kermani M., Denholm E.M., and Phan S.H. Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J. Biol. Chem. 271 (1996) 17779-17784
9. Hayashidani S., Tsutsui H., Shiomi T., Ikeuchi M., Matsusaka H., Suematsu N., Wen J., Egashira K., and Takeshita A. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 108 (2003) 134-140
10. Ho A.W., Wong C.K., and Lam C.W. Tumor necrosis factor-a up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways. Immunobiology 213 (2008) 533-544
11. Hohensinner P.J., Kaun C., Rychli K., Ben-Tal Cohen E., Kastl S.P., Demyanets S., Pfaffenberger S., Speidl W.S., Rega G., Ullrich R., Maurer G., Huber K., and Wojta J. Monocyte chemoattractant protein (MCP-1) is expressed in human cardiac cells and is differentially regulated by inflammatory mediators and hypoxia. FEBS Lett. 580 (2006) 3532-3538
12. Kobusiak-Prokopowicz M., Orzeszko J., Mazur G., Mysiak A., Orda A., Poreba R., and Mazurek W. Chemokines and left ventricular function in patients with acute myocardial infarction. Eur. J. Int. Med. 18 (2007) 288-294
13. Kohno T., Anzai T., Naito K., Sugano Y., Maekawa Y., Takahashi T., Yoshikawa T., and Ogawa S. Angiotensin-receptor blockade reduces border zone myocardial monocyte chemoattractant protein-1 expression and macrophage infiltration in post-infarction ventricular remodeling. Circ. J. 72 (2008) 1685-1692
14. Lam S.Y., Tipoe G.L., Liong E.C., and Fung M.L. Chronic hypoxia upregulates the expression and function of proinflammatory cytokines in the rat carotid body. Histochem. Cell Biol. 130 (2008) 549-559
15. Lu L., Chen S.S., Zhang J.Q., Ramires F.J., and Sun Y. Activation of nuclear factor-kappaB and its proinflammatory mediator cascade in the infarcted rat heart. Biochem. Biophys. Res. Commun. 321 (2004) 879-885
16. Malik A.A., Radhakrishnan N., Reddy K., Smith A.D., and Singhal P.C. Tubular cell-Escherichia coli interaction products modulate migration of monocytes through generation of transforming growth factor-beta and macrophage-monocyte chemoattractant protein-1. J. Endourol. 16 (2002) 599-603
17. Ren G., Dewald O., and Frangogiannis N.G. Inflammatory mechanisms in myocardial infarction. Curr. Drug Targets Inflamm. Allergy 2 (2003) 242-256
18. Sakai N., Wada T., Furuichi K., Shimizu K., Kokubo S., Hara A., Yamahana J., Okumura T., Matsushima K., Yokoyama H., and Kaneko S. MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes. J. Leukoc. Biol. 79 (2006) 555-563
19. Sun D.D., Wang H.C., Wang X.B., Luo Y., Jin Z.X., Li Z.C., Li G.R., and Dong M.Q. Tanshinone IIA: a new activator of human cardiac KCNQ1/KCNE1 (IKs)potassium channels. Eur. J. Pharmacol. 590 (2008) 317-321
20. Takahashi M., Suzuki E., Takeda R., Oba S., Nishimatsu H., Kimura K., Nagano T., Nagai R., and Hirata Y. Angiotensin II and tumor necrosis factor-{alpha} synergistically promote monocyte chemoattractant protein-1 expression: roles of NF{kappa}B, p38 and reactive oxygen species. Am. J. Physiol. Heart Circ. Physiol. 294 (2008) H2879-H2888
21. Tang F., Wu X., Wang T., Wang P., Li R., Zhang H., Gao J., Chen S., Bao L., Huang H., and Liu P. Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress. Vasc. Pharmacol. 46 (2007) 427-438
22. Tsang C.M., Wong C.K., Ip W.K., and Lam C.W. Synergistic effect of SCF and TNF-alpha on the upregulation of cell-surface expression of ICAM-1 on human leukemic mast cell line (HMC)-1 cells. J. Leukoc. Biol. 78 (2005) 239-247
23. Villarreal F.J., Kim N.N., Ungab G.D., Printz M.P., and Dillmann W.H. Identification of functional angiotensinII receptors on rat cardiac fibroblasts. Circulation 88 (1993) 2849-2861
24. Wong C.K., Ip W.K., and Lam C.W. Biochemical assessment of intracellular signal transduction pathwaysin eosinophils: implications for pharmacotherapy. Crit. Rev. Clin. Lab. Sci. 41 (2004) 79-113
25. Xia Y., and Frangogiannis N.G. MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy. Curr. Drug Targets Inflamm. Allergy 6 (2007) 101-107
26. + channels by sodium tanshinoneII-A sulfonate (DS-201) in porcine coronary artery smooth muscle cells. Eur. J. Pharmacol. 598 (2008) 9-15
27. Zhang H.S., and Wang S.Q. Nrf2 is involved in the effect of tanshinone IIA on intracellular redox status in human aortic smooth muscle cells. Biochem. Pharmacol. 73 (2007) 1358-1366
28. Zhang X., Azhar G., Nagano K., and Wei J.Y. Differential vulnerability to oxidative stress in rat cardiac myocytes versus fibroblasts. J. Am. Coll. Cardiol. 38 (2001) 2055-2062
29. Zhi-yuan F., Rong L., Bing-xiang Y., Guang-De Y., Yu L., and Hui Z. Tanshinone IIA downregulates the CD40 expression and decreases MMP-2 activity on atherosclerosis induced by high fatty diet in rabbit. J. Ethnopharmacol. 115 (2008) 217-222